ADC Therapeutics SA General and Administrative Expenses 2011-2026 | ADCT

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses ADC Therapeutics SA

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	71.5 M	55.1 M	13.8 M	8.6 M	7.81 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
71.5 M	7.81 M	31.4 M

Quarterly General and Administrative Expenses ADC Therapeutics SA

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	19 M	-	16.6 M	19.4 M	17.6 M	-	14.2 M	15 M	5.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.4 M	5.88 M	15.4 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	89.7 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	7.17 M	-	4.01 %	$ 150 M	Canada
MorphoSys AG MOR	78.3 M	-	2.43 %	$ 254 M	Germany
Adagene ADAG	14.4 M	$ 2.75	-5.5 %	$ 155 M	China
ARCA biopharma ABIO	13.1 M	-	1052.0 %	$ 415 M	USA
Albireo Pharma ALBO	69.6 M	-	-0.23 %	$ 916 M	USA
ANI Pharmaceuticals ANIP	250 M	$ 81.68	-0.39 %	$ 1.58 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.4 B	-	-	$ 40.3 B	USA
Amgen AMGN	7.1 B	$ 341.02	-0.56 %	$ 183 B	USA
Aeglea BioTherapeutics AGLE	45.8 M	-	-	$ 1.01 B	USA
Biophytis SA BPTS	7.15 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	4.95 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	4.66 M	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	17.4 M	$ 2.58	0.1 %	$ 16.2 M	USA
Alterity Therapeutics Limited ATHE	5.51 M	$ 3.18	-2.45 %	$ 7.65 B	Australia
Akero Therapeutics AKRO	37.9 M	-	-	$ 3.67 B	USA
Allena Pharmaceuticals ALNA	12.7 M	-	3.16 %	$ 1.9 M	USA
AVROBIO AVRO	24 M	-	1083.1 %	$ 745 M	USA
Aptose Biosciences APTO	11.2 M	-	-45.71 %	$ 1.2 M	Canada
Aravive ARAV	13 M	-	-13.39 %	$ 1.45 M	USA
Biogen BIIB	2.4 B	$ 178.15	1.15 %	$ 25.9 B	USA
Brickell Biotech BBI	11.2 M	-	-5.38 %	$ 6.06 M	USA
Applied Molecular Transport AMTI	37.4 M	-	-	$ 10.1 M	USA
Beam Therapeutics BEAM	112 M	$ 28.26	-3.52 %	$ 2.33 B	USA
Институт стволовых клеток человека ISKJ	25.8 M	-	-	-	Russia
Ascendis Pharma A/S ASND	160 M	$ 225.58	0.73 %	$ 5 B	Danmark
Athira Pharma ATHA	26.1 M	-	-	$ 269 M	USA
Atreca BCEL	31.5 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	286 M	$ 114.21	-2.2 %	$ 27.2 B	Germany
Burford Capital Limited BUR	99.3 M	$ 9.74	0.88 %	$ 1.52 B	Britain
Arrowhead Pharmaceuticals ARWR	124 M	$ 70.17	1.52 %	$ 9.39 B	USA
CASI Pharmaceuticals CASI	23.8 M	$ 1.0	1.5 %	$ 136 M	USA
Aeterna Zentaris AEZS	5.92 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.33 M	-	-10.17 %	$ 12.2 K	USA
Catalyst Biosciences CBIO	14.7 M	$ 9.97	-1.77 %	$ 656 M	USA
Akouos AKUS	22.2 M	-	0.23 %	$ 488 M	USA
Bellicum Pharmaceuticals BLCM	5.72 M	-	-9.72 %	$ 5.89 M	USA
Adaptimmune Therapeutics plc ADAP	73.5 M	-	-15.15 %	$ 60.3 M	Britain
Berkeley Lights BLI	95.1 M	-	-7.31 %	$ 87 M	USA
Can-Fite BioPharma Ltd. CANF	3.05 M	$ 4.05	-1.22 %	$ 8.81 B	Israel
Amneal Pharmaceuticals AMRX	476 M	$ 13.87	-1.74 %	$ 4.29 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Bellerophon Therapeutics BLPH	6.02 M	-	-74.18 %	$ 955 K	USA
Cerus Corporation CERS	75.9 M	$ 2.34	0.65 %	$ 432 M	USA
CureVac N.V. CVAC	100 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	12.7 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	18 M	-	-	$ 2.17 B	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	7.08 M	-	-11.43 %	$ 502 K	USA
Baudax Bio BXRX	24.1 M	-	0.59 %	$ 63 K	USA